Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Daniel B. Dix0
Scott M. Walsh0
Date of Patent
November 12, 2019
Patent Application Number
15603732
Date Filed
May 24, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human proprotein convertase subtilisin/kexin type 9 (PCSK9). The formulations may contain, in addition to an anti-PCSK9 antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.